These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28899583)

  • 21. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.
    Novick D; Haro JM; Suarez D; Lambert M; Lépine JP; Naber D
    Psychopharmacology (Berl); 2007 May; 191(4):1015-22. PubMed ID: 17310386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders.
    Helldin L; Kane JM; Karilampi U; Norlander T; Archer T
    Schizophr Res; 2007 Jul; 93(1-3):160-8. PubMed ID: 17395430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between symptomatic remission and functional outcome in first-episode schizophrenia.
    Bodén R; Sundström J; Lindström E; Lindström L
    Schizophr Res; 2009 Feb; 107(2-3):232-7. PubMed ID: 18957275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of symptom remission in schizophrenia during inpatient treatment.
    Jäger M; Riedel M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Bottlender R; Strauss A; Möller HJ
    World J Biol Psychiatry; 2009; 10(4 Pt 2):426-34. PubMed ID: 17853260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of a functional remission threshold for the Functional Remission of General Schizophrenia (FROGS) scale.
    Boyer L; Richieri R; Guedj E; Faget-Agius C; Loundou A; Llorca PM; Auquier P; Lançon C
    Compr Psychiatry; 2013 Oct; 54(7):1016-22. PubMed ID: 23731897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes.
    Dunayevich E; Sethuraman G; Enerson M; Taylor CC; Lin D
    Schizophr Res; 2006 Sep; 86(1-3):300-8. PubMed ID: 16860974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A state-independent network of depressive, negative and positive symptoms in male patients with schizophrenia spectrum disorders.
    van Rooijen G; Isvoranu AM; Kruijt OH; van Borkulo CD; Meijer CJ; Wigman JTW; Ruhé HG; de Haan L;
    Schizophr Res; 2018 Mar; 193():232-239. PubMed ID: 28844638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severity of core symptoms in first episode schizophrenia and long-term remission.
    Marchesi C; Affaticati A; Monici A; De Panfilis C; Ossola P; Tonna M
    Psychiatry Res; 2015 Jan; 225(1-2):129-132. PubMed ID: 25467699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive performance, symptom severity, and survival among patients with schizophrenia spectrum disorder: A prospective 15-year study.
    Helldin L; Hjärthag F; Olsson AK; Harvey PD
    Schizophr Res; 2015 Dec; 169(1-3):141-146. PubMed ID: 26391285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptom remission in first episode patients.
    Addington J; Addington D
    Schizophr Res; 2008 Dec; 106(2-3):281-5. PubMed ID: 18926666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical validation of the criteria for symptom remission in schizophrenia: preliminary findings.
    Opler MG; Yang LH; Caleo S; Alberti P
    BMC Psychiatry; 2007 Jul; 7():35. PubMed ID: 17650312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia.
    Lambert M; Naber D; Schacht A; Wagner T; Hundemer HP; Karow A; Huber CG; Suarez D; Haro JM; Novick D; Dittmann RW; Schimmelmann BG
    Acta Psychiatr Scand; 2008 Sep; 118(3):220-9. PubMed ID: 18699954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study.
    Chang WC; Hui CL; Tang JY; Wong GH; Lam MM; Chan SK; Chen EY
    Schizophr Res; 2011 Dec; 133(1-3):22-8. PubMed ID: 21968080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
    Schennach-Wolff R; Jäger M; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
    World J Biol Psychiatry; 2010 Aug; 11(5):729-38. PubMed ID: 20380620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.
    Stahl SM; Malla A; Newcomer JW; Potkin SG; Weiden PJ; Harvey PD; Loebel A; Watsky E; Siu CO; Romano S
    J Clin Psychopharmacol; 2010 Aug; 30(4):425-30. PubMed ID: 20571437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and Sociodemographic Associates of Remission from Positive Symptoms in Schizophrenia.
    Jana AK
    East Asian Arch Psychiatry; 2021 Mar; 31(1):13-18. PubMed ID: 33753572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.
    Wunderink L; Nienhuis FJ; Sytema S; Wiersma D
    Schizophr Bull; 2007 May; 33(3):792-6. PubMed ID: 16894026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.